About
Op2lysis is a biotechnology company that develops innovative medicines to safely lyse hematomas and blood clots in the brain, targeting hemorrhagic stroke using its NANOp2Lysis® technology and an optimized thrombolytic agent called OptPA.
Explore Op2lysis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.